• Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub
  •  0 items - £0.00
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • My account
  •  0 items - £0.00

Action Duchenne

Header Right

  • Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub

News

You are here: Home / News

Sofiya joins the Action Duchenne team

13 January 2023 by Lizzie Cox

A very warm welcome to Sofiya Got who has joined the Action Duchenne family as our new Science Communication Coordinator. Sofiya comes to us with …

Sofiya joins the Action Duchenne teamRead More

Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy

11 January 2023 by Lizzie Cox

Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce that the U.S. Food and Drug Administration (FDA) has accepted the new drug application …

Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular DystrophyRead More

End of Life and Bereavement Support Survey

5 January 2023 by Victoria Edwards

Parents and family members have told us once their loved ones have passed on they no longer feel part of the Duchenne community as they were …

End of Life and Bereavement Support SurveyRead More

13 December 2022 by Victoria Edwards

…

Read More

https://www.actionduchenne.org/merry-christmas/

Roche DMD Team: End of Year Duchenne Community Update

8 December 2022 by Lizzie Cox

As we approach the end of the year, Roche are providing an update to the Duchenne Community about their activities surrounding delandistrogene …

Roche DMD Team: End of Year Duchenne Community UpdateRead More

Sarepta Theraputics Gene Therapy Granted Priority Review by FDA

5 December 2022 by Lizzie Cox

Sarepta Therapeutics announced that the U.S. FDA has accepted the Company's Biologics License Application for SRP-9001 gene therapy for …

Sarepta Theraputics Gene Therapy Granted Priority Review by FDARead More

Support our new project this Christmas

30 November 2022 by Victoria Edwards

Recently my son’s needs changed, his school was struggling and without the correct equipment and training in place a decision by the local authority …

Support our new project this ChristmasRead More

Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy

4 November 2022 by Robbie Handley

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, and Rockville, MD, USA, October 27, 2022 – Santhera Pharmaceuticals (SIX: …

<strong>Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy</strong>Read More

Important update for DMD parents and carers

25 October 2022 by Robbie Handley

Important update for DMD parents and carers:DMD Care UK’s new recommendations for cardiac care have been published in the BMJ Open Heart today.You can …

Important update for DMD parents and carersRead More

Peer-to-peer support – transitioning to secondary

30 September 2022 by Lynnette

This week's Friday Hive support session (as part of the All-through Support project) we talked about transitioning to secondary school and how to make …

Peer-to-peer support – transitioning to secondaryRead More

NICE publishes draft guidance on access to Duchenne treatment Translarna

30 September 2022 by Lynnette

NICE has published draft guidance stating that although Translarna (also known as ataluren) is clinically effective and an innovative treatment, there …

NICE publishes draft guidance on access to Duchenne treatment TranslarnaRead More

Questions at the Conference

23 September 2022 by Lynnette

Action Duchenne is providing a platform for you, the Duchenne community, to ask questions from the leading Pharmaceutical companies driving …

Questions at the ConferenceRead More

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Interim pages omitted …
  • Page 49
  • Go to Next Page »

Footer

Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA

0300 102 1762
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

Site Footer

Fundraising Regulator badge with validation link

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852